olaratumab

Known as: Anti-PDGFR alpha Monoclonal Antibody IMC-3G3, Anti-Platelet-Derived Growth Factor Receptor alpha Monoclonal Antibody IMC-3G3 
A fully human IgG1 monoclonal antibody directed against the platelet-derived growth factor receptor alpha (PDGFR alpha) with potential antineoplastic… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2014-2018
051020142018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Recent randomised phase II trial data have indicated that the addition of olaratumab, a novel monoclonal antibody against… (More)
Is this relevant?
2017
2017
Over 50 investigational monoclonal antibody (mAb) therapeutics are currently undergoing evaluation in late-stage clinical studies… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2017
2017
Background This study evaluated tumor response to olaratumab (an anti-PDGFRα monoclonal antibody) in previously treated patients… (More)
  • table 2
  • table 1
  • table 3
  • table 4
  • table 5
Is this relevant?
Review
2017
Review
2017
INTRODUCTION Olaratumab is a humanized IgG1 monoclonal antibody that blocks the platelet-derived growth factor receptor alpha… (More)
Is this relevant?
Review
2017
Review
2017
Olaratumab (Lartruvo™) is a fully human IgG1 monoclonal antibody targeted against the human platelet-derived growth factor (PDGF… (More)
Is this relevant?
Review
2017
Review
2017
The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used… (More)
Is this relevant?
Review
2017
Review
2017
Soft tissue sarcoma represents about 1% of all solid malignancies. The standard chemotherapy regimens have included doxorubicin… (More)
Is this relevant?
Highly Cited
2016
Highly Cited
2016
BACKGROUND Treatment with doxorubicin is a present standard of care for patients with metastatic soft-tissue sarcoma and median… (More)
Is this relevant?
2014
2014
Olaratumab (IMC-3G3) is a fully human IgG1 monoclonal antibody that selectively binds the external domain of human platelet… (More)
Is this relevant?
2014
2014
The platelet-derived growth factor receptor (PDGFR) has an important role in tumorigenesis and tumor progression. Olaratumab (IMC… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?